PIM1 and pancreatic ductal adenocarcinoma: PIM inhibition with the pan-PIM inhibitor, SGI-1776, sensitized pancreatic ductal adenocarcinoma cells to gemcitabine and led to an increased gemcitabine-induced apoptosis26.